Dealing with missing outcome data in meta-analysis

Res Synth Methods. 2020 Jan;11(1):2-13. doi: 10.1002/jrsm.1349. Epub 2019 Jun 9.

Abstract

Missing data result in less precise and possibly biased effect estimates in single studies. Bias arising from studies with incomplete outcome data is naturally propagated in a meta-analysis. Conventional analysis using only individuals with available data is adequate when the meta-analyst can be confident that the data are missing at random (MAR) in every study-that is, that the probability of missing data does not depend on unobserved variables, conditional on observed variables. Usually, such confidence is unjustified as participants may drop out due to lack of improvement or adverse effects. The MAR assumption cannot be tested, and a sensitivity analysis to assess how robust results are to reasonable deviations from the MAR assumption is important. Two methods may be used based on plausible alternative assumptions about the missing data. Firstly, the distribution of reasons for missing data may be used to impute the missing values. Secondly, the analyst may specify the magnitude and uncertainty of possible departures from the missing at random assumption, and these may be used to correct bias and reweight the studies. This is achieved by employing a pattern mixture model and describing how the outcome in the missing participants is related to the outcome in the completers. Ideally, this relationship is informed using expert opinion. The methods are illustrated in two examples with binary and continuous outcomes. We provide recommendations on what trial investigators and systematic reviewers should do to minimize the problem of missing outcome data in meta-analysis.

Keywords: informative missingness odds ratio; informative missingness parameter; meta-analysis; missing data; missing not at random.

Publication types

  • Review

MeSH terms

  • Bias
  • Data Collection / methods*
  • Data Interpretation, Statistical*
  • Depression / drug therapy
  • Haloperidol / therapeutic use
  • Humans
  • Meta-Analysis as Topic*
  • Mirtazapine / therapeutic use
  • Models, Statistical
  • Probability
  • Randomized Controlled Trials as Topic
  • Reproducibility of Results
  • Research Design
  • Schizophrenia / drug therapy
  • Treatment Outcome
  • Uncertainty

Substances

  • Mirtazapine
  • Haloperidol